Activities of University Hospital Clinical Trial Alliance (UHCT Alliance) for Global and Domestic Clinical Trials(Session 1b)
スポンサーリンク
概要
- 論文の詳細を見る
The drug-approval process in Japan is far behind and the number of the approved drugs is far less than in other countries in the world. This lag has made it difficult for Japanese doctors to catch up with the global standards for the treatment of various diseases. This problem should be solved immediately. To overcome the drug lag and have a new drug approved without delay in Japan, it is mandatory to join multi-national clinical trials and apply for approval of a drug using the results. Therefore, several university hospitals with excellent performance in clinical trials have established UHCT Alliance to improve the trial environment, especially for multi-national trials, and to implement them more efficiently and safely.
- 2011-11-11
著者
-
Tomita Makoto
Clinical Research Center Tokyo Medical And Dental University Hospital Faculty Of Medicine
-
Goto Toshikazu
University Hospital Clinical Trial Alliance Clinical Research Center The University Of Tokyo Hospita
-
Sato Takatoshi
University Hospital Clinical Trial Alliance Clinical Research Center The University Of Tokyo Hospita
関連論文
- Activities of University Hospital Clinical Trial Alliance (UHCT Alliance) for Global and Domestic Clinical Trials(Session 1b)
- Visualizing Spatio-temporal Small Area Data of Suicide in Japan(Session 1a)
- Long-term changes of aortic ^F-FDG uptake and calcification in health-screening subjects